Search results
I took magic mushrooms at 76 to treat my depression – and it transformed my life
Daily Telegraph· 5 days agoWhat followed was “a totally joyous experience with wonderful lights and myriad colours… The sound...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...
How cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic...
San Francisco Chronicle· 4 days agoThe move comes in tandem with growing interest in the use of psilocybin, the active component in magic mushrooms, for treatment of depression, chronic pain and other conditions ...
How cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic...
Stamford Advocate· 4 days agoThe move comes in tandem with growing interest in the use of psilocybin, the active component in magic mushrooms, for treatment of depression, chronic pain and other conditions ...
How cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic...
The News-Times· 4 days agoThe move comes in tandem with growing interest in the use of psilocybin, the active component in magic mushrooms, for treatment of depression, chronic pain and other conditions ...
Earnings call: Vanda Pharmaceuticals reports mixed Q1 results, plans growth
Investing.com· 5 days agoVanda (NASDAQ: VNDA ) Pharmaceuticals Inc. (VNDA) discussed its performance in the first quarter of...
83% of Adults With Generalized Anxiety Disorder Symptoms Are Undiagnosed
MedPage Today· 6 days agoAlmost a quarter of surveyed U.S. adults met criteria for generalized anxiety disorder (GAD), though...
‘I wonder if he’s on commission’: A psychiatrist online prescribed me Prozac, punched the air in...
MarketWatch via Yahoo Finance· 7 days ago“I processed a $50 copay, and attended my appointment with the psychiatrist. It went fast, and every...
Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
GuruFocus.com via Yahoo Finance· 6 days agoExplore key financial achievements and strategic directions from Intra-Cellular Therapies' first quarter of 2024, including a significant revenue increase and promising drug development updates.
Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transc
Guru Focus· 6 days agoIntra-Cellular Therapies Inc reported a significant increase in first-quarter total revenues to $144.9 million, with CAPLYTA net sales up 53% year-over-year. Favorable safety and tolerability ...